These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20798128)

  • 1. STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5.
    Cetica V; Santoro A; Gilmour KC; Sieni E; Beutel K; Pende D; Marcenaro S; Koch F; Grieve S; Wheeler R; Zhao F; zur Stadt U; Griffiths GM; Aricò M
    J Med Genet; 2010 Sep; 47(9):595-600. PubMed ID: 20798128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes.
    Nagai K; Yamamoto K; Fujiwara H; An J; Ochi T; Suemori K; Yasumi T; Tauchi H; Koh K; Sato M; Morimoto A; Heike T; Ishii E; Yasukawa M
    PLoS One; 2010 Nov; 5(11):e14173. PubMed ID: 21152410
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Benavides N; Spessott WA; Sanmillan ML; Vargas M; Livingston MS; Erickson N; Pozos TC; McCormick ME; Scharrig E; Messinger YH; Giraudo CG
    Front Immunol; 2020; 11():545414. PubMed ID: 33162974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells.
    Côte M; Ménager MM; Burgess A; Mahlaoui N; Picard C; Schaffner C; Al-Manjomi F; Al-Harbi M; Alangari A; Le Deist F; Gennery AR; Prince N; Cariou A; Nitschke P; Blank U; El-Ghazali G; Ménasché G; Latour S; Fischer A; de Saint Basile G
    J Clin Invest; 2009 Dec; 119(12):3765-73. PubMed ID: 19884660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.
    Rohr J; Beutel K; Maul-Pavicic A; Vraetz T; Thiel J; Warnatz K; Bondzio I; Gross-Wieltsch U; Schündeln M; Schütz B; Woessmann W; Groll AH; Strahm B; Pagel J; Speckmann C; Janka G; Griffiths G; Schwarz K; zur Stadt U; Ehl S
    Haematologica; 2010 Dec; 95(12):2080-7. PubMed ID: 20823128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in STXBP2.
    Seo JY; Lee KO; Yoo KH; Sung KW; Koo HH; Kim SH; Kang HJ; Park KD; Shin HY; Baek HJ; Kook H; Lyu CJ; Song JS; Lee MJ; Kim JY; Lim YT; Koh KN; Im HJ; Seo JJ; Kim HJ;
    Clin Genet; 2016 Feb; 89(2):222-7. PubMed ID: 26451869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion.
    Spessott WA; Sanmillan ML; McCormick ME; Patel N; Villanueva J; Zhang K; Nichols KE; Giraudo CG
    Blood; 2015 Mar; 125(10):1566-77. PubMed ID: 25564401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2.
    Meeths M; Entesarian M; Al-Herz W; Chiang SC; Wood SM; Al-Ateeqi W; Almazan F; Boelens JJ; Hasle H; Ifversen M; Lund B; van den Berg JM; Gustafsson B; Hjelmqvist H; Nordenskjöld M; Bryceson YT; Henter JI
    Blood; 2010 Oct; 116(15):2635-43. PubMed ID: 20558610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis.
    Rudd E; Bryceson YT; Zheng C; Edner J; Wood SM; Ramme K; Gavhed S; Gürgey A; Hellebostad M; Bechensteen AG; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI
    J Med Genet; 2008 Mar; 45(3):134-41. PubMed ID: 17993578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel STXBP2 mutation causing familial hemophagocytic lymphohistiocytosis.
    Jain R; Puliyel M; Moses PD; Sieni E
    Indian Pediatr; 2012 Jun; 49(6):488-90. PubMed ID: 22796692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5).
    Pagel J; Beutel K; Lehmberg K; Koch F; Maul-Pavicic A; Rohlfs AK; Al-Jefri A; Beier R; Bomme Ousager L; Ehlert K; Gross-Wieltsch U; Jorch N; Kremens B; Pekrun A; Sparber-Sauer M; Mejstrikova E; Wawer A; Ehl S; zur Stadt U; Janka G
    Blood; 2012 Jun; 119(25):6016-24. PubMed ID: 22451424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the novel L243R mutation in STXBP2 reveals impairment of degranulation activity.
    Viñas-Giménez L; Donadeu L; Alsina L; Rincón R; de la Campa EÁ; Esteve-Sole A; Català A; Colobran R; de la Cruz X; Sayós J; Martínez-Gallo M
    Int J Hematol; 2020 Mar; 111(3):440-450. PubMed ID: 31865540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Characterizing the Role of the STXBP2-R190C Monoallelic Mutation Found in a Patient With Hemophagocytic Syndrome and Langerhans Cell Histiocytosis.
    Viñas-Giménez L; Rincón R; Colobran R; de la Cruz X; Celis VP; Dapena JL; Alsina L; Sayós J; Martínez-Gallo M
    Front Immunol; 2021; 12():723836. PubMed ID: 34630398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis.
    Zhang K; Chandrakasan S; Chapman H; Valencia CA; Husami A; Kissell D; Johnson JA; Filipovich AH
    Blood; 2014 Aug; 124(8):1331-4. PubMed ID: 24916509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bi-Allelic Mutations in STXBP2 Reveal a Complementary Role for STXBP1 in Cytotoxic Lymphocyte Killing.
    Lopez JA; Noori T; Minson A; Li Jovanoska L; Thia K; Hildebrand MS; Akhlaghi H; Darcy PK; Kershaw MH; Brown NJ; Grigg A; Trapani JA; Voskoboinik I
    Front Immunol; 2018; 9():529. PubMed ID: 29599780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Screening for cytotoxic defects with flow cytometric detection of CD107α on natural killer cells and cytotoxic lymphocyte cells].
    Wang J; Liu Z; Jiang LP; An YF; Zhao XD
    Zhonghua Er Ke Za Zhi; 2012 May; 50(5):386-91. PubMed ID: 22883044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 binding.
    Cetica V; Hackmann Y; Grieve S; Sieni E; Ciambotti B; Coniglio ML; Pende D; Gilmour K; Romagnoli P; Griffiths GM; Aricò M
    J Allergy Clin Immunol; 2015 May; 135(5):1310-8.e1. PubMed ID: 25312756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Munc13-4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis.
    Santoro A; Cannella S; Bossi G; Gallo F; Trizzino A; Pende D; Dieli F; Bruno G; Stinchcombe JC; Micalizzi C; De Fusco C; Danesino C; Moretta L; Notarangelo LD; Griffiths GM; Aricò M
    J Med Genet; 2006 Dec; 43(12):953-60. PubMed ID: 16825436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Genetic Analysis of Nine Suspected Familial Haemophagocytic Lymphohistiocytosis Patients for MUNC13-4 Deficiency and Introducing Four Novel Mutations in UNC13D.
    Vahidi M; Badalzadeh M; Jannesar M; Mazinani M; Fazlollahi MR; Khodayari Namini N; Houshmand M; Hamidieh AA; Moradi L; Pourpak Z; Moin M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):487-492. PubMed ID: 32245292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in neutrophil granule mobilization and bactericidal activity in familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) syndrome caused by STXBP2/Munc18-2 mutations.
    Zhao XW; Gazendam RP; Drewniak A; van Houdt M; Tool AT; van Hamme JL; Kustiawan I; Meijer AB; Janssen H; Russell DG; van de Corput L; Tesselaar K; Boelens JJ; Kuhnle I; Van Der Werff Ten Bosch J; Kuijpers TW; van den Berg TK
    Blood; 2013 Jul; 122(1):109-11. PubMed ID: 23687090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.